Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0023380 (
lethargy
)
5,697
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A progressive neurological illness characterized by myoclonus, motor and sensory deficits, and
lethargy
occurred in a patient with Hodgkin's disease and was fatal within two months. A focal inclusion cell encephalitis was demonstrated by immunohistological means to be due to
measles
virus.
Measles
encephalitis must be considered a potential opportunistic agent in the immune-compromised host.
...
PMID:Subacute measles encephalitis complicating Hodgkin's disease in an adult. 21 19
Subacute sclerosing panencephalitis (SSPE) is a progressive neurodegenerative disease caused by the
measles
(
rubeola
) virus and is most often seen in children. Many affected children have a history of
measles
infection in the first years of life or exposure to the live
measles
virus vaccine. Typically, there is a rapid onset of neurological symptoms degenerating into a
stuporous
state in the patient. Four children and their families are reviewed. Their individual courses, medical and nursing problems and interventions, and implications for immunizations with the
measles
-mumps-rubella (MMR) vaccine will be discussed.
...
PMID:SSPE: but we thought measles was gone! 201 70
Among 16 cases of
measles
encephalitis observed in Toronto during 1964 and 1965, including six who were
stuporous
or comatose on admission and five who presented with convulsions,
measles
virus was isolated from CSF of one patient, rising titres of
measles
antihemagglutinin were detected in another patient, and 14 showed high antibody titres in sera collected as early as two to five days after onset of the
measles
rash. Increasing levels of
measles
antibody were detected in paired sera from three of seven patients with uncomplicated
measles
, and elevated antihemagglutinin titres were found in 16 cases of
measles
without neural involvement.
Measles
virus was isolated from lung tissue of a fatal case of giant cell pneumonia. Administration of pooled human gamma globulin to one leukemic patient, and of leukocytes from a convalescent donor to another leukemic child, may have assisted their recovery from
measles
.
...
PMID:Viral infections of Toronto children during 1965: II. Measles encephalitis and other complications. 495 71
The intracerebral inoculation of hamster neurotropic
measles
virus produces a fatal acute encephalopathy in the majority of weanling BALB/c mice. The few survivors remain healthy indefinitely. In contrast, weanling SJL/J mice are relatively resistant to acute encephalopathy, and about one-third of the survivors predictably develop a chronic encephalitis many weeks after inoculation. This later illness is characterized clinically by wasting,
lethargy
, seizures, or focal paralysis, usually culminating in death. Pathologically, a considerable brain inflammatory response occurs in association with abundant
measles
viral antigen. Viral antigen and inflammation were demonstrable predominantly in the limbic system but was also present in the cerebellum and brain stem. Antibody to
measles
virus was readily demonstrated in all animals with chronic encephalitis. This report constitutes the first description of chronic
measles
encephalitis in an inbred host.
...
PMID:Chronic measles encephalitis in mice. 744 Oct 20
A patient with subacute sclerosing panencephalitis (SSPE) was treated with an intraventricular alpha interferon (IFN-alpha) through an Ommaya reservoir. A 17-year-old boy, who had a history of
measles
exposure at age 1, showed forgetfulness, difficulties in calculation, reading and writing. Two months later he developed generalized convulsions and myoclonic spasms. He was admitted to the National Saigata Hospital in May 20, 1992. On admission, anti-
measles
antibody titer in the CSF was 1:16 by complement-fixation method. His EEG revealed a periodic synchronous discharge. Therefore, the diagnosis of SSPE was confirmed. An Ommaya reservoir was implanted on July 7, 1992, and an intraventricular administration of INF-alpha was begun after two weeks. The dose of INF-alpha was gradually increased from 1.0 x 10(6) IU/m2 to 2.0 x 10(6) IU/m2 twice a week. Fever, vomiting and anorexia were developed when the INF-alpha injection was first started. When he received a total dose of 8.0 x 10(6) IU, he became bed ridden for remarkable
lethargy
. The
lethargy
was continued for about 10 days despite the therapy was interrupted, and then he gradually became alert. The frequency of myoclonus became more frequent and mentality got worse, so the treatment with INF-alpha was tried again in decreasing the dose to 1.0 x 10(6) IU/m2 twice a week. However, be became drowsy again after he received a total of 7.5 x 10(6) IU. With intramuscular or intravenous administrations of the high doses of INF-alpha (> or = 1.0 x 10(7) IU), significant neurological abnormalities were reported to occur.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:[A case of subacute sclerosing panencephalitis treated with intraventricular interferon--the side effects of interferon-alpha to the central nervous system]. 815 18
Each year,
measles
kills more than 1 million children in developing countries, especially malnourished children and children with complications. Prompt hospital admission is required to prevent
measles
-associated deaths if children with
measles
exhibit a general danger sign (
lethargy
or unconsciousness, convulsions, inability to eat or drink, or vomiting), signs of xerophthalmia, deep or extensive mouth ulcers, severe pneumonia, severe dehydration, or severe malnutrition. No drug can treat this viral infection;
measles
management consists of treating complications. Health workers must insert a nasogastric tube to administer liquid foods and fluids in children with severe
measles
who cannot eat. They should clean both eyes with a clean cloth and water 3 times a day. They should apply tetracycline eye ointment 3 times a day for 7 days. They should give a child with signs of xerophthalmia a treatment dose of vitamin A and another dose 3 weeks later. Health workers need to clean the mouth with clean water and a pinch of salt at least 4 times a day and put 1% gentian violet on mouth sores after cleaning. They should treat an anaerobic mouth infection, indicated by a foul smelling discharge, with metronidazole.
Measles
patients with an acute ear infection should receive paracetamol for pain and fever and an antibiotic for the infection. In the case of ear discharge, the health worker must clean the ears at least twice a day with cotton wool or a clean cloth. They should encourage mothers of
measles
patients with diarrhea to continue breast feeding. Health workers must administer more fluids than usual. They need to monitor hospitalized children to detect any additional complications. They need to look for danger signs; record the child's temperature, pulse, and respiratory rate twice a day; and weigh the child daily. Children with
measles
must be isolated for 4 days after onset of the rash. Any child in contact with the ill child should receive a dose of
measles
vaccine if he/she has not already been vaccinated or had
measles
. A vaccine coverage rate of at least 90% is the best way to prevent
measles
and
measles
-associated deaths.
...
PMID:Preventing measles deaths. 1229 69
A 23-year-old man presented with disturbance of consciousness and convulsion. Two weeks prior to his admission, he had general arthralgia, retro-orbital pain, and body temperature increase to 40 degrees C. These symptoms persisted for two weeks. He was admitted to the hospital because of general convulsion, followed by disturbance of consciousness. On admission, he was deeply
lethargic
. Cerebrospinal fluid obtained on admission showed pleocytosis (247/mm3) and an increased level of protein. Electroencephalogram obtained on admission disclosed diffuse slow waves. Enhanced cranial MR image did not show any abnormal lesions in the cerebral parenchyma. The patient was diagnosed as having meningoencephalitis and the treatment consisting of aciclovir, CTRX, and methylprednisolone was undertaken. A test for human immunodeficiency virus (HIV) antibody was found to be positive on the second day of hospitalization. A Western blot was positive with bands at gp160 and P24 confirming HIV infection. Antibody titers of paired acute and convalescent sera including HSV, EBV, CMV, mumps,
measles
, and Japanese encephalitis did not show any significant increase. The patient became alert on the 3rd day of hospitalization. Electroencephalogram obtained on the 10th day of hospitalization was normal. Western blot, which was obtained 4 months later, was positive with bands at gp120, p68, p55, p52, gp41, p40, p34, p18, including gp160 and P24. He was diagnosed as having primary HIV infection. Meningoencephalitis was attributed to acute primary HIV infection. Acute HIV infection should be considered as an etiology of meningoencephalitis.
...
PMID:[A case of primary HIV infection presenting as meningoencephalitis]. 1631 72
Measles
virus (MV) infection causes an acute childhood disease, associated in certain cases with infection of the central nervous system and development of a severe neurological disease. We have generated transgenic mice ubiquitously expressing the human protein SLAM (signaling lymphocytic activation molecule), or CD150, recently identified as an MV receptor. In contrast to all other MV receptor transgenic models described so far, in these mice infection with wild-type MV strains is highly pathogenic. Intranasal infection of SLAM transgenic suckling mice leads to MV spread to different organs and the development of an acute neurological syndrome, characterized by
lethargy
, seizures, ataxia, weight loss, and death within 3 weeks. In addition, in this model, vaccine and wild-type MV strains can be distinguished by virulence. Furthermore, intracranial MV infection of adult transgenic mice generates a subclinical infection associated with a high titer of MV-specific antibodies in the serum. Finally, to analyze new antimeasles therapeutic approaches, we created a recombinant soluble form of SLAM and demonstrated its important antiviral activity both in vitro and in vivo. Taken together, our results show the high susceptibility of SLAM transgenic mice to MV-induced neurological disease and open new perspectives for the analysis of the implication of SLAM in the neuropathogenicity of other morbilliviruses, which also use this molecule as a receptor. Moreover, this transgenic model, in allowing a simple readout of the efficacy of an antiviral treatment, provides unique experimental means to test novel anti-MV preventive and therapeutic strategies.
...
PMID:High pathogenicity of wild-type measles virus infection in CD150 (SLAM) transgenic mice. 1677 30